• 5-ALA
• Acute Myeloid Leukemia Cooperative Group (AMLCG)
• ADAM
• Aided-Trial
• Adjuvante antimikrobielle Therapie von Parondontitis (ABParo)
• AML Survivorship – Psychosoziale, somatische und genetische Spätfolgen einer AML Erkrankung
• AXADIA
• BARGRU
• BARGRU-II
• BIBF 1120 in AML
• B-NHL 2013
• ClaiMS
• ELIAS
• EPIS-AKI
• ES-RiP
• EU-RHAB-Register
• Evaluation des Pulsoxymetrie-Screenings (POS)
• EWING
• Fabry Disease
• GD2+ IL18 CART
• GDL-ISRT 20 Gy
• GenderVasc
• Glacé-Trial
• HandiCAP
• HIT-Endo/Kraniopharyngeom
• HIT-HGG
• HIT Life
• HIT/SIOP-PNET
• ICARE- Integrating Technology in Mental Health Care Delivery in Europe
• InMediValue
• LOGGIC
• NEOCYST
• NOA 11-Studie
• OptAHF
• oVID
• PARTNER-Studie
• PREDICT-IVI
• PREVENT-JIA
• Prognostic performance of a genetic risk score for melanoma
• PSA-Inform
• RB-Registry
• RICH-TRIAL
• RIT in GBM
• RTPS 1+2
• SeFallED
• SIOPe ATRT01
• SMN after sarcomas
• SOLKID-GNR
• SoLKID-Studie
• tTF-NGR Phase II/III Study – STS (TRABTRAP)
• T-HAPLO-SCT for SCD
• TOSYMA
• WIN-SAB
• YCMB-LR